Blood Res.  2021 Dec;56(4):347-349. 10.5045/br.2021.2021147.

Immune thrombocytopenic purpura worsened by COVID-19

• Kim CS
• Choi DR
• Lee JH

• KMID: 2524099
• DOI: http://doi.org/10.5045/br.2021.2021147

Figure

• 

  Fig. 1 Platelet count dropped suddenly on day 181, and eltrom-bopag dose was tripled from 25 mg QD to 75 mg QD on the same day. The day of docetaxel admini-stration is indicated by arrows. The platelet response to eltrombopag appears prominent on day 390 immediately after the second dose of docetaxel administered on day 388, similar to that seen on days 2–86 after the first dose of docetaxel was administered on day 1.Abbreviation: QD, one a day.

• 

  Fig. 2 Chest radiograph shows no evidence of pneumonia, except for persistent interstitial infiltrates due to chronic idiopathic pulmonary fibrosis. Abbreviations: PA, posteroanterior; RT, right.

Reference

1. Simonovich VA, Burgos Pratx LD, Scibona P, et al. 2021; A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N Engl J Med. 384:619–29. DOI: 10.1056/NEJMoa2031304. PMID: 33232588. PMCID: PMC7722692.

2. Horby P, Lim WS, et al. RECOVERY Collaborative Group. 2021; Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 364:693–704. DOI: 10.1056/NEJMoa2021436. PMID: 32678530. PMCID: PMC7383595.

3. Bhattacharjee S, Banerjee M. 2020; Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med. 1–11. DOI: 10.1007/s42399-020-00521-8. PMID: 32984764. PMCID: PMC7501509.

4. Hu Z, Chen W, Liang W, Xu C, Sun W, Yi Y. 2021; Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report. Ann Hematol. 100:2135–7. DOI: 10.1007/s00277-020-04070-x. PMID: 32500224. PMCID: PMC7270513.

5. Kondo Y, Kaneko Y, Oshige T, et al. 2021; Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus. Ann Rheum Dis. 80:e77. DOI: 10.1136/annrheumdis-2020-218157. PMID: 32759254.

6. Merli M, Ageno W, Sessa F, et al. 2020; Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection. Ann Hematol. 99:1951–2. DOI: 10.1007/s00277-020-04130-2. PMID: 32529284. PMCID: PMC7288620.